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Abstract
Whether certain Epstein-Barr virus (EBV) strains are associated with pathogenesis of nasopharyngeal carcinoma (NPC) is still
an unresolved question. In the present study, EBV genome contained in a primary NPC tumor biopsy was amplified by
Polymerase Chain Reaction (PCR), and sequenced using next-generation (Illumina) and conventional dideoxy-DNA
sequencing. The EBV genome, designated HKNPC1 (Genbank accession number JQ009376) is a type 1 EBV of approximately
171.5 kb. The virus appears to be a uniform strain in line with accepted monoclonal nature of EBV in NPC but is
heterogeneous at 172 nucleotide positions. Phylogenetic analysis with the four published EBV strains, B95-8, AG876, GD1,
and GD2, indicated HKNPC1 was more closely related to the Chinese NPC patient-derived strains, GD1 and GD2. HKNPC1
contains 1,589 single nucleotide variations (SNVs) and 132 insertions or deletions (indels) in comparison to the reference
EBV sequence (accession number NC007605). When compared to AG876, a strain derived from Ghanaian Burkitt’s
lymphoma, we found 322 SNVs, of which 76 were non-synonymous SNVs and were shared amongst the Chinese GD1, GD2
and HKNPC1 isolates. We observed 88 non-synonymous SNVs shared only by HKNPC1 and GD2, the only other NPC tumor-
derived strain reported thus far. Non-synonymous SNVs were mainly found in the latent, tegument and glycoprotein genes.
The same point mutations were found in glycoprotein (BLLF1 and BALF4) genes of GD1, GD2 and HKNPC1 strains and might
affect cell type specific binding. Variations in LMP1 and EBNA3B epitopes and mutations in Cp (11404 C.T) and Qp (50134
G.C) found in GD1, GD2 and HKNPC1 could potentially affect CD8+ T cell recognition and latent gene expression pattern in
NPC, respectively. In conclusion, we showed that whole genome sequencing of EBV in NPC may facilitate discovery of
previously unknown variations of pathogenic significance.
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Introduction
Epstein-Barr virus (EBV) is a ubiquitous human gammaherpes-
virus infecting more than 90% of the world’s population and is
associated with both non-malignant disease, such as infectious
mononucleosis, as well as malignant diseases, such as nasopha-
ryngeal carcinoma (NPC), endemic Burkitt’s lymphoma, Hodg-
kin’s disease, B- and T-cell lymphomas and rare cases of gastric
carcinoma [1]. The EBV genome comprises approximately
170 kb and contains at least 86 open reading frames. The virus
genome contains a long unique region interspersed by four major
internal repeats (IR1 to IR4) and terminal repeats (TR). Nine
latent proteins including Epstein-Barr nuclear antigen 1 (EBNA1),
EBNA2, EBNA3A, -3B, -3C, EBNA-LP and latent membrane
protein 1 (LMP1) and LMP2A, -2B are encoded by genes situated
in the unique region of the genome [1]. Other open reading
frames encode capsid proteins, transcription factors as well as lytic
proteins of various functions [2]. In addition to protein-coding
genes, EBV genome also encodes non-coding EBV RNAs, such as
Epstein-Barr virus–encoded small RNA 1 (EBER1) and 2 (EBER2),
BART-derived microRNAs (miRNAs-BARTs) and BHRF1 micro-
RNAs (miRNAs-BHRF1) [3,4].
Four complete or partial EBV genomes, B95-8, AG876, GD1
and GD2, have been reported. The prototypic EBV strain B95-8 is
the first complete genome sequenced and was derived from an
individual with infectious mononucleosis [5]. A more representa-
tive type 1 EBV reference genome (Genbank accession:
NC_007605) was constructed using B95-8 as the backbone while
an 11-kb deleted segment was provided by Raji sequences [6].
AG876 originated from a Ghanaian case of Burkitt’s lymphoma
and is the only complete type 2 EBV sequence available to date
[7,8]. GD1 and GD2 are EBV genomes derived from NPC
patients from the Guangdong province of southern China. GD1
was isolated from saliva of a NPC patient [9], while GD2 was
isolated from an NPC tumor [10].
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The consistent association of undifferentiated NPC with EBV
implies that EBV plays a causal role in NPC development. Type 1
& 2 EBV have long been observed to display a characteristic
geographical prevalence [11]. Similarly, the incidence of NPC has
a remarkable geographical pattern, as it is much more frequent in
Southeast Asia, North Africa, and Alaska than in the rest of the
world [12]. The concordance of geographical distribution of EBV
strains and the endemic incidence of NPC have prompted studies
to investigate whether distinct strains of EBV might contribute to
disease. EBV strains have previously been characterized in NPC
tumors using strain-specific markers in the EBER1 and -2, LMP1,
BHRF1, BZLF1 and EBNA1 loci in samples from China, south
Asia, and northern Africa [13–18]. These genes were chosen
either because they are expressed in NPC, or they play an
important role in the EBV infectious cycle. LMP1 deletions and
point mutations were suggested to be associated with lymphopro-
liferative diseases [19]. The frequent association of an LMP1
deletion variant Asp335 with NPC in Hong Kong was also
reported [20]. Similarly, evidence supports a role for selection of
a del-LMP1 over the wt-LMP1 variants in NK/T-cell lymphoma
in the same Hong Kong population [21]; a specific EBNA1
subtype (V-val), also showed preferential occurrence in NPC
biopsies [22]. These observations support the notion of pathogenic
strains in NPC. However, functional assays on seven LMP1
variants failed to show differences in vitro transformation assays or
in observed signaling properties [23]. Despite these results, the
continued predominance of China 1, an LMP1 variant observed in
NPC tumor over other strains found in circulation [24] argued for
the selection of contributory strains in tumorigenesis. Genetic
variations in the small subsets of genes investigated thus far are not
sufficient for unequivocal identification of all but a small number
of EBV strains to assess their geographical distribution and precise
association to disease. There is an unmet need for further whole
genome sequencing analysis of EBV.
GD1 was the EBV genome sequenced from saliva of a NPC
patient using PCR amplification and sub-cloning followed by
conventional dideoxy-based DNA sequencing. GD2 was the first
EBV sequence determined by the so termed next-generation
sequencing technology. Using the Illumina (Solexa) platform, the
sequence of the GD2 genome was recently obtained from random
shotgun sequencing and assembly of total DNA sequences derived
from the primary NPC tumor [10]. However, sequencing total
cellular & viral DNA in a sample is costly and inefficient due to the
relatively small quantity of viral DNA present in the tumor sample,
thereby limiting the generation of the high read depth necessary to
make high confident base calls of the viral genome. One way in
dealing with the problem is to use target enrichment technology to
increase the relative amount of viral DNA [25]. Here we reported
another approach of PCR enrichment (Amplicon Sequencing)
followed by sequencing the amplified products on the Illumina
Genome Analyzer IIx platform to determine the genome sequence
of an EBV isolate from NPC tumor of a Chinese patient in Hong
Kong. The EBV genome sequence was assembled with reference
to wild type EBV and designated as HKNPC1 (Genbank accession
number JQ009376). Phylogenetic analysis was performed on
HKNPC1 and the four EBV strains available in Genbank. We
compared the distribution of synonymous and non-synonymous
base differences in the four EBV strains and assessed their
potential roles in pathogenesis. Although geographic variations
may account for many mutations detected, we identify a glycopro-
tein SNV as potential marker of epithelial viral strains, and
mutations in Cp and Qp latent promoters to which may contribute
to latent gene expression pattern in NPC. We also identify
variations in EBNA3B epitopes, which may alter CD8+ T cell
recognition. Future elucidation of additional EBV genomes in
NPC tumors and local wild type EBV strains is warranted to
provide further insights relating geographical distribution to
disease.
Results
Summary of sequencing data of HKNPC1 genome
The non-repetitive regions of the HKNPC1 genome, repre-
sented by 60 overlapping amplicons, were generated using pairs of
PCR primers targeting previously recognized regions of sequence
conservation. A total of 3,417,075 sequence reads of 76-base pair-
end reads were generated resulting in 260 Mb of sequence data
from the combined pool of amplicons. Sequence read that passed
default quality control filters on the Illumina platform were aligned
to EBV reference genome (accession number NC007605)
sequence followed by BLAST procedure against nucleotide
database to determine the sequence identity. 91.99% (3,143,389)
of the reads can be mapped to the reference genome indicating the
high specificity of the amplicon generation. The aligned sequence
covered 99.98% of the expected amplified regions of the EBV
genome. Only base positions with a read depth of at least 5 reads
were used to tabulate the consensus sequence of HKNPC1.
Enrichment of EBV sequence by PCR before Illumina DNA
sequencing enabled a high average read depth of 1,688-fold across
the targeted region with approximately 52% of the PCR-amplified
regions of HKNPC1 having greater than 1,000-fold read depth
coverage (Table 1, Figure 1). We attempted to validate ambiguous
positions with insufficient read depth (less than 5 reads) by
dideoxy-based DNA sequencing. However, 153 nucleotide posi-
tions remained unvalidated and were marked as N in the genome
sequence. One copy of internal repeat 1 (IR1) and one copy of
terminal repeat (TR) were sequenced by conventional dideoxy-
based sequencing, whilst the copy numbers of IR1 and TR of
reference EBV genome were adopted in our assembly. The gaps in
39 flanking region of IR-1, IR-2, and IR-4 (reference EBV
coordinates 35,273–36,132; 38,194–40,615; and 139,950–
143,125, respectively) were also represented by tracts of Ns.
Accordingly, the present study represents a useful high-resolution
draft comprising all the known coding and regulatory sequences
but has not resolved all the repetitive regions. The HKNPC1 draft
genome is approximately 171,549 bp with GC-content of 59.5%.
It was annotated using the information derived from the reference
EBV sequence. The high sequence depth allowed us to assess
genetic heterogeneity within our isolate. A position was defined to
be homogeneous if the variant frequency is.=95% and a position
to be heterogeneous if the variant frequency is between 20% and
94%, both homogenous and heterogeneous positions require read
depth to be 5 or above While we could not completely rule out
artifactual sequence alterations that might occur during amplicon
generation or during Illumina sequencing, we identified a total of
172 potential heterogeneous nucleotide positions in HKNPC, of
which 143 were located in repeat sequences throughout the
genome. The remaining 29 heterogeneity positions were distrib-
uted within the coding sequences of the latent genes EBNA1, -2, -
3A, and LMP1; the tegument protein genes, BPLF1, BOLF1 and
BGLF1; other genes such as BVLF1, BFLF2 and BFRF3; and
within the intergenic regions (Table S1).
HKNPC1 showed closer phylogenetic relationship to GD1
and GD2 than B95-8 and AG876
Single nucleotide variations (SNVs) in the consensus HKNPC1
genome compared to the reported strains were extracted by
cross_match (http://www.phrap.org/phredphrapconsed.html).
Sequencing and Comparative Analysis of HKNPC1
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After masking the repeat regions, a high density of SNVs was
observed in the previously reported polymorphic EBNA2, EBNA3
and LMP1 loci (Figure 2A). The region where BMRF1 resided had
low SNV density, with no SNV present from positions 67,659 to
69,061 (HKNPC1 coordinates). Pairwise alignment of HKNPC1
with the four reported strains was performed and visualized by
mVISTA (http://genome.lbl.gov/vista/mvista/submit.shtml)
(Figure 2B). Multiple whole sequence alignment of HKNPC1
and the other four EBV subtypes were performed using MAFFT
[26] employing Gblocks [27] to mask poorly aligned positions and
divergent regions of the aligned sequences. Overall sequence
similarities between HKNPC1 and the four other strains were
high, reaching 98.6% (B95-8), 98.5% (GD1), 95% (GD2) and
96.6% (AG876), respectively. Expectedly, low similarity regions
coincided with regions of high SNV density, exemplified in the
polymorphic regions spanning EBNA2 and EBNA3A, -3B and -3C.
The three type 1 EBV genomes, B95-8, GD1 and GD2, have
higher sequence similarity with HKNPC, particularly in the
regions spanning EBNA2 and EBNA3, indicating that HKNPC1 is
a type 1 virus. Neighbour-joining trees constructed using software
Figure 1. Circular representation of HKNPC1 genome. Numbered tracks represent the following: (1) PCR amplicons prepared for next-
generation sequencing (NGS); (2) reverse open reading frames; (3) forward open reading frames; (4) repeat regions; (5) read depth of NGS reads,
height of the track represents 10,000 reads; single nucleotide variations (SNVs) and indels of (6) HKNPC1, (7) GD1, (8) GD2, and (9) AG876, in
comparison to reference EBV sequence. This figure was created using Circos software [37].
doi:10.1371/journal.pone.0036939.g001
Table 1. Depth and coverage of reads of HKNPC1.
Read Depth Mapped data (bp) Percentage coverage of PCR-amplified regions
.= 1 141,468 99.98%
.10 141,233 99.82%
.100 138,321 97.76%
.500 116,966 82.66%
.1000 74,028 52.32%
doi:10.1371/journal.pone.0036939.t001
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MEGA5 [28] showed that GD1, GD2 and HKNPC1 are more
closely related (Figure 3A). Gene trees generated from alignment
of translated amino acid sequences of BZLF1, LMP1 and EBNA1
provided the same result (Figure 3B to 3D). Sequences of these
genes were subsequently validated by dideoxy-based sequencing.
Single nucleotide variations (SNVs) shared by Chinese
derived GD1, GD2 and HKNPC1
HKNPC1 contains 1,589 single nucleotide variations (SNVs)
and 132 indels when compared to the reference EBV genome
(Accession no. NC007605). Of the 1,589 SNVs, 1,167 had a read
depth of 100 or above. The remaining 422 SNVs with read depth
less than 100 were verified by dideoxy-DNA sequencing. While
1,043 of the SNVs were found in coding sequence, none were
located within the consensus TATA box or PolyA adenylation
motifs. The Chinese derived GD1, GD2 and HKNPC1 isolates
shared 642 SNVs when compared to the reference genome
(Figure 4A). Discounting SNVs found in AG876, which is derived
from Ghanaian Burkitt’s lymphoma, 332 SNVs remained (orange
region in figure 4A) with 76 of these representing non-synonymous
nucleotide changes (Table S2 and figure 4). Since GD1 originated
from saliva of a NPC patient, GD2 and HKNPC1 represent the
only two direct NPC tumor-derived strains reported thus far. By
considering SNVs that are shared only between these two tumor-
derived strains, additional 347 SNVs were identified (blue region
in figure 4A) of which 88 were non-synonymous mutations (Table
S2 and figure 4). Of note, the total number of SNVs found in
HKNPC1 isolate would be underestimated due to incompleteness
of the genome. However, the number of shared SNVs among
GD1, GD2 and HKNPC1 strains would still be accurately
represented in our comparative analyses since the majority of
shared SNVs among viral strains are predominantly located at the
non-repeat regions of the genome. In total, we reported 164 non-
synonymous SNVs among the three viral strains. A large
proportion of them is located in latent (59/164) and tegument
(46/164) proteins, followed by glycoproteins (14/164) (figure 4C,
Table S2). The remaining SNVs were situated in genes encoding
proteins involving in replication, packaging, transcription, capsid
structure, or those of unknown function (Table 2).
Shared SNVs in protein-encoding sequences
Compared to the reference genome, all latent genes of the two
tumor-derived EBV strains, GD2 and HKNPC1, harbor non-
synonymous SNVs. LMP1 and -2 have the highest number of non-
synonymous mutations, 14 and 12 SNVs, respectively. All but one
such SNV in LMP1, and all those in EBNA1, were shared amongst
GD1, GD2 and HKNPC1. All non-synonymous SNVs in LMP2,
EBNA2 and EBNA3s except one in EBNA3C, were shared by GD2
and HKNPC1. The majority of SNVs in LMP1, and all SNVs in
LMP2, resulted in amino acid changes in transmembrane region of
the encoded proteins (Figure 5). Cytoplasmic domains of LMP1
and -2, which carry out important biological function, are more
conserved. Based on strain-determining amino acids of EBNA1
(A487V, D499E and T524I) and C-terminus of LMP1 (G212S,
Q334R, L338S), HKNPC1 can be classified into the V-val and
China 1 genotypes. A 30-bp deletion is also found in LMP1,
leading to a 10-amino acid deletion in the C-terminus of the
encoded protein, as in GD1, GD2 and AG876. Among the non-
synonymous SNV-containing tegument loci, BPLF1, and BRRF2,
have the highest number of shared SNVs (18 and 10 SNVs,
respectively). The 18 non-synonymous SNVs in the tegument loci
are distributed among BNRF1, BGLF1, BKRF4, BSLF1 and
Figure 2. Comparison of HKNPC1 genome to other EBV genomes. (A) Genome-wide distribution of SNVs of HKNPC1. Coordinates of SNVs
were extracted by cross_match software and a density plot was constructed using 500-bp non-overlapping windows. (B) Similarity graphs of
reference EBV, GD1, GD2 and AG876 compared against HKNPC1. The four genomes generally have high sequence identity with HKNPC1, except
repeat regions (brown) and polymorphic genes (blue). EBNA2, EBNA3A, -3B, and -3C show lower identity in AG876 (type 2), than the other three type 1
EBV genomes. The figure was generated by mVISTA software, using 100-bp moving window with minimum identity of 70% and maximum identity of
100%.
doi:10.1371/journal.pone.0036939.g002
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Figure 3. Phylogenetic analysis of the five EBV genomes. Phylogenetic tree based on DNA and protein sequences of the five EBV strains. (A)
DNA sequence of complete genome of the five strains, with poorly aligned and highly divergent sequences masked by Gblocks. Phylogenetic trees
based on protein sequence alignment of (B) BZLF1, (C) LMP1, and (D) EBNA1 were generated. All these trees showed a closer distance among the
three NPC-related EBV strains, GD1, GD2, and HKNPC1, than the other two viral strains. Phylogenetic analysis was performed using MEGA software
(version 5), by Neighbor-joining (NJ) algorithm. Divergence scale, in numbers of substitution per site, is shown under each tree.
doi:10.1371/journal.pone.0036939.g003
Figure 4. Summary of single nucleotide variations and non-synonymous mutations in GD1, GD2 and HKNPC1 genomes. (A) Number
of single nucleotide variants (SNVs) of HKNPC1, GD1, GD2 and AG876 with each genome compared against reference EBV. The orange region
represents the 322 SNVs shared by GD1, GD2 and HKNPC1 with exclusion of those of AG876, whereas the blue region represents the 347 SNVs shared
by GD2 and HKNPC1 with exclusion of those of AG876 and GD1. (B) Non-synonymous SNVs shared by GD1, GD2 and HKNPC1 were categorized by
protein function based on the work of Tabouriech et al. [2]. (C) Non-synonymous SNVs shared by GD1, GD2 and HKNPC1 and those shared by GD2
and HKNPC1 were pooled together and categorized by function of the genes.
doi:10.1371/journal.pone.0036939.g004
Sequencing and Comparative Analysis of HKNPC1
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BRLF1. The glycoprotein-encoding genes, BDLF3, BLLF1, BALF4
and BKRF2, which encode gp150, gp350, gB and gL, respectively,
contained shared SNVs. Three non-synonymous mutations in
BZLF1 shared by the two NPC-derived strains, were not located in
the known DNA-binding region.
Variations in latent EBV-specific epitopes
Amongst the shared non-synonymous SNVs of the Chinese
derived GD1, GD2 and HKNPC1 isolates, 34 are associated in
known EBV-specific epitopes (Table S3); 19 and 15 are found in
CD8+ and CD4+ epitopes, respectively. Amino acid changes in
CD8+ epitopes were identified in all latent proteins, including
EBNA1, -2, -3A, -3B, -3C, and LMP1 and -2, while only EBNA1,
-2, LMP1 and -2 contain residue changes in CD4+ epitopes. Five
CD8+ epitopes harboring amino acid changes were identified to be
restricted through HLA alleles particularly common in the
southern Chinese population. AVF and IVT epitopes in EBNA3B
and SSC epitope in LMP2 are restricted through HLA 1 A11,
whereas the FRR epitope in LMP1 and IED are restricted through
HLA 1 B40.
Variations in non-coding genes and promoter sequences
MicroRNAs in BHRF1 (miR-BHRF1) region and BART region
(miR-BART) and Epstein-Barr virus–encoded small RNAs (EBERs)
are non-coding genes. Genes encoded for microRNAs BHRF1
(miR-BHRF1-1 to -3) and EBER1 are highly conserved with no
variations among the five strains, whereas in the miR-BARTs, only
a single point mutation (147,821 T.A) was observed in the
sequence encoding miR-BART19-5p. Variations were observed in
EBER2, however, only one point mutation (7,048 A.C) is shared
by GD2 and HKNPC1, and other mutations are not exclusive to
NPC-derived strains. The BZLF1 promoter was classified to be
variant Zp-V3 based on strain-defining mutations at 2196, 2141,
2106 and 2100 from the transcription start site. Although no
mutations were identified in known and predicted TATA boxes,
sequence changes of 11,324 G.T and 11,404 C.T in Cp, and
49,937 G.A and 50,134 G.C in Qp were observed. Mutations at
11,324, 11,404 and 44,937 were present in GD1, GD2 and
HKNPC1, but not in AG876 and wild type, while mutation at
50,134 was found in GD2 and HKNPC1, but not in the other
three strains.
Discussion
Genotyping studies to date have focused on different regions of
EBV, making comparisons across studies difficult, and limiting our
ability to define the full spectrum of diversity within the EBV
genome. Many studies aimed to identify NPC-specific strains
focused only on a limited number of genes expressed in NPC,
predominantly EBNA1, LMP1, LMP2A, BZLF1, miR-BART, and
EBER1 and -2. We extended our analysis across other regions of
the genome and identified a host of SNVs shared among the three
NPC-associated strains. By only considering mutations common in
HKNPC1, GD1 and GD2, false positives caused by sequencing
errors can be minimized. Since it is known that latent genes are
polymorphic, it is not surprisingly that we observed a concentration
of non-synonymous SNVs among latent genes in our study. We
also observe a significant number of SNVs in the genes encoding
the tegument proteins and the glycoproteins.
Studies of EBV’s role in NPC pathogenesis were mainly
restricted to genes expressed in NPC. The role of other EBV life
cycle genes in NPC has not been well studied. One question
related to the EBV infectious cycle is whether there is preferential
entry of certain EBV strains into epithelial cells. Such a mechanism
may involve membrane glycoproteins, which are responsible for
cell type specific binding. The GD2 and HKNPC1 strains were of
epithelial origin, while B95-8 and AG876 were from Burkitt’s
lymphoma cell lines. Despite the fact that GD1 was not directly
harvested from epithelial tissue of an NPC patient, it is reasonable
to assume that GD1 is also an epithelial strain released from
lymphoepithelial organ (mucosa-associated lymphoid tissue, e.g.,
tonsils) into saliva. Non-synonymous mutations in glycoprotein
genes BLLF1 (79,265 C.G) and BALF4 (157,568 C.T) were
Table 2. EBV genes with non-synonymous single nucleotide
variations shared by NPC-derived EBV strains.
Category Gene Protein product No. of SNVs*
Capsid BVRF2 Protease 2
BTRF1 Capsid 2
BVRF1 Portal plug 2
Glycoprotein BDLF3 gp150 4
BLLF1 gp350 4
BALF4 gB 4
BKRF2 gL 2
Latent EBNA1 EBNA1 7
EBNA2 EBNA2 7
EBNA3A EBNA3A 5
EBNA3B EBNA3B 8
EBNA3C EBNA3C 6
LMP1 LMP1 15
LMP2A LMP2A 12
Packaging BGRF1/BDRF1 Terminase small
subunit
1
BFLF1 BFLF1 3
Replication BALF5 Polymerase 1
BALF2 BALF2 3
BBLF2/BBLF3 Primase-associated
factor
6
Tegument BNRF1 Major tegument
protein
3
BRRF2 unknown function 10
BOLF1 LTP-binding protein 4
BPLF1 Large tegument
protein
18
BGLF1 BGLF1 2
BKRF4 BKRF4 3
BSLF1 Primase 5
BRLF1 Rta 1
Transcription
factor
BHRF1 bcl-2 homolog 1
BSLF2/BMLF1 SM protein 3
BBRF1 portal protein 1
BZLF1 Zta 3
BBRF2 BBRF2 2
unknown BFRF2 unknown function 9
BcRF1 unknown function 3
BFRF1A unknown function 2
*SNVs, single nucleotide variations.
doi:10.1371/journal.pone.0036939.t002
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found common in HKNPC1, GD1 and GD2. These mutations
cause amino acid changes at the CR2 receptor binding site of
gp350 (E201Q) and at the furin cleavage site of gB (D433N)
proteins, respectively. However, the functional consequences of
these mutations are not known. Comparison of the sequences of
NPC-derived EBV genomes with those of lymphoid-derived EBV
genomes of the same individuals or individuals of the same
population may contribute to our understanding of the signifi-
Figure 5. Location of amino acid changes of EBV proteins encoded by GD1, GD2 and HKNPC1 genomes. Amino acids changes in EBV
proteins with known or putative function due to non-synonymous SNVs are marked by arrows. Red arrows indicate amino acid changes shared by
HKNPC1, GD1 and GD2, but not in AG876. Blue arrows indicate amino acid changes shared by HKNPC1 and GD2, but not in GD1 and AG876. Known
or predicted cytoplasmic domain (brown), transmembrane domain (green) and extracellular domain (yellow) of membrane proteins are illustrated.
Black bars represent specialized features of BALF4 (glycoprotein B), EBNA1, LMP1, EBNA1 and BPLF1.
doi:10.1371/journal.pone.0036939.g005
Sequencing and Comparative Analysis of HKNPC1
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cance of these mutations. Variants of two HLA A11-restricted
immunodominant epitopes in EBNA3B protein were found in
HKNPC1. These were AVF epitope with a mutated fourth residue
(D.N) and IVT epitope with a mutated ninth residue (K.N) and
were reported to be poorly recognized by IVT- and AVF-specific
cytotoxic T cells compared to the wild-type epitopes [29]. Of
interest, computer-based analysis suggested these non-immuno-
genic variant epitopes were under positive selection by the
immune system [30]. A substitution of Leu to Phe was found in
the second residue of an HLA A2-restricted epitope YLL of LMP1
protein. This substitution was found to be more prevalent in viral
strains contained in NPC specimens than those in adjacent non-
neoplastic nasopharyngeal tissue of southern Chinese and
Taiwanese patients [31]. The EBNA3B and LMP1 variant
epitopes might contribute to evasion from T-cell surveillance.
HKNPC1, GD1 and GD2 strains shared the Cp mutation (11404
C.T), whereas only GD2 and HKNPC1 shared the Qp mutation
(50134 G.C). It was reported that the mutation in Cp reduced its
promoter activity while that in Qp increased its activity [32].
Furthermore, both mutations were found to be more prevalent in
EBV strains harbored in NPC tumors than in peripheral blood
mononuclear cells [32].
We observed a number of heterogeneous nucleotide positions in
HKNPC1. The majority of these positions were found in different
repeat regions of the EBV genome. These heterogeneous
nucleotide positions could be caused by polymerase slippage in
sequencing or arise during amplicon generation. With our high
sequencing depth, it is also possible that some of the observed
sequence heterogeneity was contributed by low numbers of
infiltrating lymphocytes in undifferentiated NPC or by actual
heterogeneity of the viral population within the tumor. Neverthe-
less, low number of heterogeneous positions observed is consistent
with the current view of monoclonal origin of EBV in NPC The
possibility of a low level of spontaneous mutations occurring
during the course of clonal expansion should be further in-
vestigated.
A recent study reported the characterization of an EBV genome
contained in a NPC biopsy, designated GD2, by direct shotgun
sequencing of the total tumor DNA. However, the yield of reads of
the viral genome was very low, comprising less than 0.014% of the
total sequence reads, from an average of no more than six copies
of EBV per tumor cell [10]. In contrast, the present amplicon-
based sequencing approach yielded mappable reads of more than
90%, thereby greatly increasing the efficiency and economy of
next-generation sequencing technology. We envisage that direct
EBV sequencing would be difficult for non-tumor or mixed tumor
sample with low viral load without the use of an enrichment step.
In addition to amplicon sequencing, it should be feasible to apply
sequence capturing technologies used in human exome sequencing
to EBV sequence enrichment as exemplified by the recent study of
specific capture and whole-genome sequencing of herpesvirus
genome from clinical samples [25]. These and other approaches
might further reduce cost and time in whole-genome sequencing
to enable larger survey of a much greater number of EBV isolates.
In summary, we have reported the sequence of an EBV genome
isolated from a primary NPC tumor, designated HKNPC1,
through amplicon sequencing on the Illumina platform. Compar-
ative analysis reveals variations not only in genes expressed in
NPC but also in genes encoding for tegument proteins,
glycoproteins and other proteins. A number of single nucleotide
variants with potential contribution to NPC pathogenesis is found
in the HKNPC1 genome. The results showed the importance of
developing a high throughput sequencing approach for direct
determination of hundreds of EBV genome sequences to in-
vestigate the epidemiological and pathogenic roles of EBV strain
variation in EBV-associated diseases.
Materials and Methods
Ethics Statement
The NPC tumor was biopsied after obtaining written consent
from a 20-year-old Chinese male patient diagnosed in 2008 with
nasopharyngeal carcinoma of stage T3N3aM1 prior to treatment
at Queen Mary Hospital, Hong Kong, China. Collection of NPC
biopsies was approved by Institutional Review Board of The
University of Hong Kong/Hospital Authority Hong Kong West
Cluster for the purpose of EBV genome sequencing in NPC
tumors.
NPC tumor specimen
Primary tumor material was biopsied by Prof. Dora LW
Kwong. Fresh NPC tumor biopsy was temporarily stored in PBS
with 1% fetal bovine serum, and DNA extraction was performed
within one hour after incision, by Qiagen Blood and Tissue Kit
according to the manufacturer’s protocol (Qiagen, Hilden,
Germany).
PCR amplication of EBV fragments
Overlapping amplicons representing the non-repetitive regions
of the EBV genome were generated using 60 sets of primers (Table
S4) and HotstarTaq Plus Kit (Qiagen). 100 ng of tumor DNA was
performed using 50 ml reaction mixture, containing 3 ml each of
10 mM forward and reverse primers, 1 ml of 10 mM deoxynucleo-
tide triphosphate (dNTPs), 0.2 ml HotstarTaq Plus enzyme, 5 ml
buffer and 10 ml Q solution provided by the kit. Thirty to forty
cycles of denaturation (94uC for 45 s), annealing (56uC for 45 s)
and extension (72uC for 2 to 6 min) were carried out in automated
thermal cycler, where cycle number and extension time depend on
length of product. The primer sequences are shown in Table S4 in
the supplementary material. Internal repeats and terminal repeats
were excluded in PCR. The products were purified by QIAquick
PCR purification kit (Qiagen) and QIAEX II gel extraction kit
(Qiagen), and were normalized to equal molecular quantity before
combining for DNA sequencing.
Sequence analysis and construction of the HKNPC1
genome
Purified pooled PCR products were fragmented randomly by
nebulization. DNA fragments were end-repaired using DNA
Terminator End Repair kit (Lucigen, WI, USA), and purified
using the QIAquick PCR Purification kit (Qiagen), according to
company’s protocol. 39 dA-tailing was carried out by Klenow
Fragment (Enzymatics, MA, USA). The dA-tailed DNA fragments
were separated and purified on 8% polyacylamide gels (Life
Technologies, CA, USA), and a gel slice of insert size ,100–
125 bp was excised and purified using QIAquick Gel Extraction
kit (Qiagen). Illumina (CA, USA) Solexa paired-end adaptors were
ligated to the purified DNA fragments by Rapid T4 DNA Ligase
(Enzymatics). The fragments were amplified for 12 cycles with
AccuPrime Pfx DNA Polymerase (Life Technologies). A final size
selection of the amplified library was performed using a 2% Low
Range Ultra agarose gel (BioRad, CA, USA). The Illumina library
was extracted in TE using MinElute Gel Extraction kit (Qiagen).
Finally, the library concentration was measured on NanoDrop
spectrophotometer (Thermo Scientific, DE, USA) and quantified
by quantitative PCR. Sequencing run of 76-base paired-end was
performed as manufacturer’s recommendations [33]. We carried
out quality assessment on the raw reads using Illumina’s default
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36939
parameters to remove reads that were of low quality or comprise
adaptor sequences or homopolymer sequences. The high quality
reads were aligned to the reference EBV genome (NC_007605)
using Burrows-Wheeler Aligner (BWA) version 0.5.8c [34].
Nucleotide variations were identified by using SAMTools [35]
with VarScan version 2.2 [36] and by in-house scripts. We defined
a position to be homogeneous if the variant frequency is .=95%
and a position to be heterogeneous if the variant frequency is
between 20% and 94% (both read depth of 5 or above).
Nucleotide positions with read depth less than 5 were classified
as ambiguous sites as there is insufficient depth to make a high
confidence call.
Sequence validation
Regions where ambiguous sites are clustered were verified by
PCR amplification with specific primers (Table S5) followed by
subsequent conventional dideoxy-DNA sequencing. 100 ng of
genomic DNA (100 ng in total) was added to a 25 ml reaction
mixture, containing 1.5 ml each of 10 mM forward and reverse
primers, 0.5 ml of 10 mM deoxynucleotide triphosphate (dNTPs),
0.1 HotstarTaq enzyme, 2.5 ml buffer and 5 ml Q solution
provided by the kit. Forty cycles of denaturation (94uC for 45 s),
annealing (56uC for 45 s) and extension (72uC for 1 min) were
carried out in automated thermal cycler. The products were
purified by QIAEX II gel extraction kit (Qiagen).
Phylogenetic analysis
A global comparison and visualization of HKNPC1 against
EBV-WT, GD1, GD2 and AG876 was performed by mVISTA
(http://genome.lbl.gov/vista/mvista/submit.shtml), using 100-bp
moving window. Phylogenetic analysis was performed using
Molecular Evolutionary Genetics Analysis (MEGA) software,
version 5.0 [28], by Neighbor-joining (NJ) algorithm, based on
multiple sequence alignments of the five whole genomes and
individual genes using MAFFT [26]. Poorly aligned sequences
were masked by Gblocks [27] before construction of phylogenetic
trees.
Comparative analysis of NPC-EBV genome with
prototype genomes
Lists of SNVs and indels were generated for each pairwise
comparison of the HKNPC1, GD1, GD2 and AG876 against
NC_007605 using cross_match software (http://www.phrap.org/
phredphrapconsed.html). SNVs in HKNPC1 with read depth of
100 or above were considered to be accurate. Dideoxy-DNA
sequencing was performed to verify those with read depth less than
100. These lists were compared against one another and SNVs
which were found to be common in GD1, GD2 and HKNPC1
were sorted out. Subsequently, SNVs also found in AG876 were
removed from the list. Similarly, a list of SNVs shared only by
GD2 and HKNPC1 were generated by subtracting the common
SNVs of GD2 and HKNPC1 from those found in GD1 and
AG876. Non-synonymous mutations were tabulated from these
sorted lists of SNVs and were categorized by known and putative
function of proteins where these non-synonymous mutations were
located. Shared SNVs located in known epitopes in coding
sequences, and non-coding features, including TATA boxes,
polyA signals, microRNAs, and other non-coding RNAs, were also
examined.
Nucleotide sequence accession number. The full-length
sequence of HKNPC1 was submitted to the Genbank database
and assigned accession number JQ009376.
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